Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells

被引:314
|
作者
Cham, Candace M. [1 ,2 ]
Driessens, Gregory [2 ]
O'Keefe, James P. [1 ,2 ]
Gajewski, Thomas F. [1 ,2 ,3 ]
机构
[1] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
[3] Univ Chicago, Hematol Oncol Sect, Dept Med, Chicago, IL 60637 USA
关键词
cellular activation; cytotoxicity; gene regulation; T cells;
D O I
10.1002/eji.200838289
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We recently reported that differentiation of CD8(+) T cells from the naive to the effector state involves the upregulation of glucose-dependent metabolism. Glucose deprivation or inhibition of glycolysis by 2-deoxy-D-glucose (2-DG) selectively inhibited production of IFN-gamma but not of IL-2. To determine a more global role of glucose metabolism on effector T-cell function, we performed gene array analysis on CD8(+) effector T cells stimulated in the presence or absence of 2-DG. We observed that expression of only 10% of genes induced by TCR/CD28 signaling was inhibited by 2-DG. Among these were genes for key cytokines, cell cycle molecules, and cytotoxic granule proteins. Consistent with these results, production of IFN-gamma and GM-CSF, cell cycle progression, upregulation of cyclin D2 protein, cytolytic activity, and upregulation of granzyme B protein and also conjugate formation were exquisitely glucose-dependent. In contrast to glucose, oxygen was little utilized by CD8(+) effector T cells, and relative oxygen deprivation did not inhibit these CTL functional properties. Our results indicate a particularly critical role for glucose in regulating specific effector functions of CD8(+) T cells and have implications for the maintenance of the effector phase of cellular immune responses in target tissue microenvironments such as a solid tumor.
引用
收藏
页码:2438 / 2450
页数:13
相关论文
共 50 条
  • [1] Functional heterogeneity of human effector CD8+ T cells
    Takata, Hiroshi
    Naruto, Takuya
    Takiguchi, Masafumi
    BLOOD, 2012, 119 (06) : 1390 - 1398
  • [2] Treg and Oligoclonal Expansion of Terminal Effector CD8+ T Cell as Key Players in Multiple Myeloma
    Joshua, Douglas E.
    Vuckovic, Slavica
    Favaloro, James
    Lau, Ka Hei Aleks
    Yang, Shihong
    Bryant, Christian E.
    Gibson, John
    Ho, Phoebe Joy
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [3] Distinct Effector Programs of Brain-Homing CD8+ T Cells in Multiple Sclerosis
    Koetzier, Steven C.
    van Langelaar, Jamie
    Melief, Marie-Jose
    Wierenga-Wolf, Annet F.
    Corsten, Cato E. A.
    Blok, Katelijn M.
    Hoeks, Cindy
    Broux, Bieke
    Wokke, Beatrijs
    van Luijn, Marvin M.
    Smolders, Joost
    CELLS, 2022, 11 (10)
  • [4] Rapid clearance of herpes simplex virus type 2 by CD8+ T cells requires high level expression of effector T cell functions
    Nelson, Michelle H.
    Bird, Melanie D.
    Chu, Chin-Fun
    Johnson, Alison J.
    Friedrich, Brian M.
    Allman, Windy R.
    Milligan, Gregg N.
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2011, 89 (01) : 10 - 17
  • [5] Comprehensive gene expression analysis of human NK cells and CD8+ T lymphocytes
    Obata-Onai, A
    Hashimoto, S
    Onai, N
    Kurachi, M
    Nagai, S
    Shizuno, K
    Nagahata, T
    Mathushima, K
    INTERNATIONAL IMMUNOLOGY, 2002, 14 (10) : 1085 - 1098
  • [6] Regulators of Glucose Metabolism in CD4+ and CD8+ T Cells
    Palmer, Clovis S.
    Hussain, Tabinda
    Duette, Gabriel
    Weller, Thomas J.
    Ostrowski, Matias
    Sada-Ovalle, Isabel
    Crowe, Suzanne M.
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2016, 35 (06) : 477 - 488
  • [7] Acthar Gel Inhibits the Activation of CD4+ and CD8+ T Cells
    Wright, Dale
    Hayes, Kyle
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2023, 43 (04) : 182 - 187
  • [8] Characterization of Effector Memory CD8+ T Cells in the Synovial Fluid of Rheumatoid Arthritis
    Bon-A Cho
    Ji Hyun Sim
    Ji Ah Park
    Hye Won Kim
    Wan-Hee Yoo
    Seung-Hyun Lee
    Dong-Sup Lee
    Jae Seung Kang
    Young-Il Hwang
    Wang Jae Lee
    Insoo Kang
    Eun Bong Lee
    Hang-Rae Kim
    Journal of Clinical Immunology, 2012, 32 : 709 - 720
  • [9] GSDMD is required for effector CD8+ T cell responses to lung cancer cells
    Xi, Guangmin
    Gao, Jianwei
    Wan, Bing
    Zhan, Ping
    Xu, Wujian
    Lv, Tangfeng
    Song, Yong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 74
  • [10] CD160 expression on CD8+ T cells is associated with active effector responses but limited activation potential in pancreatic cancer
    Songyang Liu
    Wei Zhang
    Kai Liu
    Yingchao Wang
    Cancer Immunology, Immunotherapy, 2020, 69 : 789 - 797